Familial Hypercholesterolemia Latest Advances
Find the Latest Research About Familial Hypercholesterolemia
Last Updated: 11/08/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9664 publications
Coronary artery calcium scoring and coronary computed tomography angiography in familial hypercholesterolemia: current evidence and future directions.
Journal: Current opinion in lipidology
Published: October 26, 2026
Estimated Small Dense LDL Cholesterol and Coronary Artery Disease in Familial Hypercholesterolemia.
Journal: Journal of atherosclerosis and thrombosis
Published: October 25, 2026
Corrigendum to "Optimizing treatment in homozygous familial hypercholesterolemia: Monocentric observational clinical study on efficacy and safety of evinacumab and lomitapide combination" [J Clin Lipidol 20 (2026) 1086-1096].
Journal: Journal of clinical lipidology
Published: October 22, 2026
Enlicitide: The First Oral PCSK9i for Lowering Low-Density Lipoprotein Cholesterol.
Journal: The Annals of pharmacotherapy
Published: October 14, 2026
Corrigendum to "Ischemic stroke and intracranial large-artery disease risk in familial hypercholesterolemia: A prospective Japanese study" [Atherosclerosis, 415, (2026), 120674].
Journal: Atherosclerosis
Published: October 09, 2026
Designing to Implement Genomics Informed ASCVD Risk Assessment: Patient and Clinician Perspectives about Identifying and Managing the Underlying Causes of Severe Hypercholesterolemia.
Journal: medRxiv : the preprint server for health sciences
Published: October 08, 2026
Comment on "Chronic kidney disease is associated with worse survival after revascularization in subjects with genetically diagnosed familial hypercholesterolemia and significant coronary artery disease".
Journal: American heart journal plus : cardiology research and practice
Published: October 08, 2026
Variant-Specific Rewiring of Lysosomal Positioning by STARD9 Produces Opposite Cholesterol Trafficking Outcomes.
Journal: bioRxiv : the preprint server for biology
Published: October 01, 2026
Diagnosis of familial hypercholesterolaemia through population screening.
Journal: Expert review of cardiovascular therapy
Published: September 28, 2026
Lerodalcibep-liga as an Injectable Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9)-Targeted Therapy for Patients With Hypercholesterolemia.
Journal: The Annals of pharmacotherapy
Published: September 25, 2026
N-aldehyde modified phosphatidylethanolamines formed by lipid peroxidation inhibit efferocytosis.
Journal: bioRxiv : the preprint server for biology
Published: September 24, 2026
Last Updated: 11/08/2026